Market Place
Sourcing Support
Novo Nordisk A/S: Trading In Shares By Board Members & Executives
19 Nov 2024 //
GLOBENEWSWIRE
Essence Ph 3 Shows Semaglutide 2.4 mg Benefits for MASH at AASLD
19 Nov 2024 //
PR NEWSWIRE
Novo Nordisk launches obesity drug Wegovy in China
19 Nov 2024 //
REUTERS
Novo to gradually phase out production of human insulin pens
16 Nov 2024 //
FIERCE PHARMA
Omega halts sole clinical-stage asset to focus on 3 programs
15 Nov 2024 //
FIERCE BIOTECH
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
13 Nov 2024 //
REUTERS
Novo Nordisk A/S: Trading by Board, Execs & Associates
13 Nov 2024 //
GLOBENEWSWIRE
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
US Minority Veterans Face Unequal Access to Ozempic, Wegovy
11 Nov 2024 //
REUTERS
Novo Nordisk Share Trading by Board Members, Execs & More
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk Purchases DKK 4.7B B Shares in Repurchase
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
08 Nov 2024 //
GLOBENEWSWIRE
Novo Share Trading by Board Members, Execs & Associated Person
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk Reports Share Trading by Board & Executives
07 Nov 2024 //
GLOBENEWSWIRE
Novo discards $1.3B kidney drug in wake of phase 3 fail
07 Nov 2024 //
FIERCE BIOTECH
Novo expects high demand for its obesity drugs in India
07 Nov 2024 //
REUTERS
Novo Nordisk Reports 23% Sales Growth in First 9 Months of 2024
06 Nov 2024 //
GLOBENEWSWIRE
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
06 Nov 2024 //
FIERCE PHARMA
Novo affirms 25% weight-loss for experimental drug CagriSema
06 Nov 2024 //
REUTERS
Novo CFO says 2025 sales could see high-teens percentage growth
06 Nov 2024 //
REUTERS
Novo`s Wegovy weight-loss drug sales beat forecast, shares jump
06 Nov 2024 //
REUTERS
Novo is aware of 10 deaths from compounded weight-loss drug copies
06 Nov 2024 //
REUTERS
Novo Nordisk A/S - share repurchase programme
05 Nov 2024 //
GLOBENEWSWIRE
Catalent Misses Q1 Revenue Estimates Before Novo Holdings Deal
05 Nov 2024 //
REUTERS
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
05 Nov 2024 //
BIOSPACE
AstraZeneca says experimental obesity pill safe in early-stage trial
05 Nov 2024 //
REUTERS
Novo`s trial of weight-loss drug improvement in fatty liver disease
04 Nov 2024 //
REUTERS
Select Trial: Semaglutide Reduces Hospital Admissions in Obesity
03 Nov 2024 //
PR NEWSWIRE
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
02 Nov 2024 //
FIERCE PHARMA
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
Novo Nordisk`s semaglutide delivers in phase 3 MASH study
01 Nov 2024 //
FIERCE PHARMA
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
FDA says lowest dose of Novo`s weight-loss drug available
31 Oct 2024 //
REUTERS
STEP 9 Study: Semaglutide Reduces OA Pain in Obesity Patients
30 Oct 2024 //
PR NEWSWIRE
Novo Nordisk`s Semaglutide Facility Cited by FDA After Inspection
30 Oct 2024 //
ENPTS
FDA Issues Form 483 to Novo Nordisk
29 Oct 2024 //
FDA
Novo Nordisk A/S - share repurchase programme
28 Oct 2024 //
#N/A
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Study
25 Oct 2024 //
BIOSPACE
CDC revamps last year`s `Wild to Mild` flu vaccine campaign
24 Oct 2024 //
FIERCE PHARMA
Weight-loss drugs didn`t curb health costs within two years
24 Oct 2024 //
REUTERS
Novo asks US to stop compounding weight-loss drug copies
24 Oct 2024 //
REUTERS
US Medicaid say cost a key factor for weight-loss drug coverage
23 Oct 2024 //
REUTERS
Novo oral diabetes drug cuts heart-related risks by 14% in study
22 Oct 2024 //
REUTERS
Catalent Issues Open Letter On Pending Acquisition By Novo Holdings
21 Oct 2024 //
BUSINESSWIRE
Novo Nordisk A/S - share repurchase programme
21 Oct 2024 //
GLOBENEWSWIRE
Europe`s CHMP backs Novo`s FDA-rejected hemophilia treatment
19 Oct 2024 //
FIERCE PHARMA
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
15 Oct 2024 //
FIERCE BIOTECH
Catalent to sell New Jersey facility
15 Oct 2024 //
REUTERS
Novo Nordisk A/S - share repurchase programme
14 Oct 2024 //
GLOBENEWSWIRE
Wegovy maker Novo bets big on talent, AI partnerships in India
11 Oct 2024 //
ECONOMICTIMES
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
11 Oct 2024 //
BIOSPACE
US Senator Warren calls for scrutiny of Novo Holdings` Catalent deal
10 Oct 2024 //
REUTERS
Novo Holding Launches Booster Therapeutics For Proteasome Activator
10 Oct 2024 //
PR NEWSWIRE
WeightWatchers to offer compounded version of Novo`s weight-loss drug
08 Oct 2024 //
REUTERS
Novo Nordisk Launches Initiative To Prevent Childhood Obesity
08 Oct 2024 //
GLOBENEWSWIRE
Novo Nordisk A/S – Share repurchase programme
07 Oct 2024 //
GLOBENEWSWIRE
Compounding Group Sues FDA Over Lilly`s Weight Loss Drug
07 Oct 2024 //
REUTERS
Novo Nordisk to invest $158 million in insulin plant in Brazil
05 Oct 2024 //
REUTERS
US FDA says Lilly`s weight-loss drug no longer in shortage
03 Oct 2024 //
REUTERS
Lilly to invest $4.5B on new facility to scale-up drug production
02 Oct 2024 //
REUTERS
